Specialised imaging modalities, particularly nuclear imaging and magnetic resonance imaging, and biomarkers of α-synuclein pathology demonstrate high sensitivity and specificity for not only early diagnosis but also differential diagnosis between other parkinsonisms. Here, SNCA is linked to Parkinson disease.